Comparison of Two Method Antimetabolites Application on Corneal Function in Trabeculectomy Surgery
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Application of antimetabolite agents such as mitomycin_c has improved trabeculectomy results
and better control of intraocular pressure complications such as corneal endothelial cell
loss. However, Mitomycin_c can be applied remain a concern before or after sclera flap
dissection. Mitomycin_c application after sclera flap dissection probably increases corneal
endothelial cell loss. This study compares Mitomycin_c application two methods: before and
after sclera flap dissection with regard to success rate and complication. patients on base
of Mitomycin_c application time (1-2-3) minutes will be match randomise in to two groups(
before and after sclera flap dissection) corneal. Endothelial cell density, polymorphism,
polymegathism and intraocular pressure before and one month, three months, six months after
surgery will measured.